Digital health industry pioneer to drive substance use management company’s strategic vision and growth
NEW YORK, November 13, 2024 — Pelago, the leading digital clinic partner to U.S. businesses and health plans for substance use management, today announced the appointment of Frank Jennings as President. With more than 30 years of experience in sales strategy and business development across various technology sectors, Jennings will play a pivotal role in driving Pelago’s strategic vision and growth.
“We’re pleased to welcome Frank to our leadership team as we expand our reach and prepare for continued expansion,” said Yusuf Sherwani, M.D., CEO and co-founder of Pelago. “As a pioneer in the digital health market, his passion for improving health outcomes and changing lives aligns perfectly with our mission to transform substance use management by creating a world where everyone has access to substance use support by breaking down barriers to substance use care that works.”
Frank Jennings joins Pelago from Castlight Health, where he served as Senior Vice President and Chief Sales Officer. Prior to Castlight, Jennings served as Chief Commercial Officer at Covera Health and Vice President of Sales, North America, at Doctor on Demand.
“I’m honored to join Pelago during such a pivotal time in the company’s journey. Their innovative approach to substance use management is changing lives, improving outcomes, and setting new standards for substance use care,” said Jennings. “Pelago’s clinically validated approach, powerful cost-saving metrics and nationwide reach are changing the face of substance use care. I look forward to furthering Pelago’s efforts to provide accessible and effective substance use support across the continuum of care.”
Pelago is revolutionizing substance use management and leading the industry with its 3x ROI and 100% fees-at-risk business model based on validated clinical outcomes and performance metrics. Pelago’s substance use platform includes specialized treatment for tobacco, alcohol, opioid and cannabis use disorders, including support for adolescents.
About Pelago
Pelago is the leading specialty substance use care provider for employers and health plans, delivering virtual, evidence-based care for alcohol, tobacco, opioid, and cannabis use. Its integrated care model combines digital tools, live counseling, and medication-assisted treatment, with same-day access available nationwide. Built by leading addiction specialists, Pelago is the only substance use care solution with published, peer-reviewed evidence demonstrating both clinical impact and medical cost savings. Through its outcomes-backed approach, Pelago helps organizations reduce high-cost medical claims while providing a confidential, stigma-free benefit that employees trust. Today, over 4 million people have access to Pelago.
Say hello to brighter days together
Get started quickly. Save costs. Change lives forever.